MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2019 International Congress

    Bilateral Globus pallidus interna Deep Brain Stimulation in Cranio-Cervical Dystonia (Meige syndrome) patient in Hong Kong

    C. Lau, C. Zhu, D. Chan, K. Ma, L. Au, A. Chan, R. Wong, J. Yeung, W. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To report the first cranio- cervical dystonia (Meige syndrome) patient who received Deep Brain Stimulation (DBS) implant in Hong Kong. Background: Meige syndrome is…
  • 2019 International Congress

    Rapid improvement in dystonia after pallidal deep brain stimulation in a patient with myoclonus-dystonia syndrome: A case report

    L. Deuel, J. Thompson, L. Kahn, J. Barr, A. Abosch, D. Kern (Aurora, CO, USA)

    Objective: Describe the time course of clinical response to bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) in a patient with myoclonus-dystonia syndrome (M-D),…
  • 2019 International Congress

    Safety of Iron Chelation in Patients with Brain Iron Overload

    C. Fradette, T. Klopstock, L. Neumayr, I. Karin, G. Zorzi, T. Kmieć, B. Büchner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, F. Zibordi, N. Nardocci, A. Stilman, M. Spino, E. Vichinsky, F. Tricta (Toronto, ON, Canada)

    Objective: To assess the safety of iron chelation in the treatment of regional brain iron overload. Background: Excess brain iron is evident in neurodegenerative diseases…
  • 2019 International Congress

    Pediatric Deep Brain Stimulation in Secondary Dystonia using Stereotactic Depth Electrode Targeting

    M. Liker, T. Sanger (Los Angeles, CA, USA)

    Objective: The primary objective of our pediatric clinical research is to improve outcomes after deep brain stimulation for pediatric patients with secondary dystonia. We apply…
  • 2019 International Congress

    Successful treatment of secondary dystonia with deep brain stimulation of the globus pallidus internus

    S. Hendrickx, PH. Bourgeois, A. Tieleman, D. Vanhauwaert, T. Couvreur, O. van Damme (Roeselare, Belgium)

    Objective: Improving targeting accuracy in the treatment of secondary dystonia with DBS of GPi Background: Dystonia is a very disabling disease. Deep brain stimulation (DBS) of…
  • 2019 International Congress

    Benefit and Weakness with botulinum toxin: time course and relationship.

    P. Kassavetis, K. Alter, C. Lungu, B. Karp (Bathesda, MD, USA)

    Objective: To compare the timecourse of and relationship between benefit and weakness after botulinum toxin (BoNT) injection. Background: The timecourse of benefit onset and duration…
  • 2019 International Congress

    GPi DBS does not affect sensory thresholds in hereditary/idiopathic dystonia

    C. Listik, R. Gisbert Cury, V. da Silva, S. Carvalho Barbosa Casagrande, E. Listik, L. Link, R. Galhardoni, E. Reis Barbosa, M. Jacobsen Teixeira, D. de Andrade (Sao Paulo, Brazil)

    Objective: Despite the widespread use of DBS for dystonia, little is known about its effects on non-motor symptoms such as dystonia-related pain. Here we provide…
  • 2019 International Congress

    Impact of pallidal deep brain stimulation on activities of daily living in patients with craniocervical dystonia – a multi-center survey

    J. Huebl, T. Andermann, C. Blahak, J. Krauss, M. Südmeyer, J. Volkmann, K. Bötzel, A. Wolters, A. Kühn (Berlin, Germany)

    Objective: To assess the impact of pallidal deep brain stimulation (DBS) on activities of daily living (ADL) in patients with primary craniocervical dystonia (CD). Background:…
  • 2019 International Congress

    Clinical hypnosis in functional movement disorders: a potential therapeutic strategy

    C. Buiza-Aguado, C. Ordas-Bandera, M. Guillan-Rodriguez, J. Del Val, PJ. Garcia Ruiz-Espiga, JC. Martinez-Castrillo, I. Parees-Moreno, A. Alonso-Canovas (Madrid, Spain)

    Objective: To present a patient with a functional movement disorder who was successfully treated with clinical hypnosis. Background: Functional movement disorders (FMD), specially fixed dystonia,…
  • 2019 International Congress

    The effect of Kinesio Taping therapy on Cervical Dystonia

    J. Magalhães, A. Rosso, F. Rezende (Rio de Janeiro, Brazil)

    Objective: To test the efficacy of kinesio taping treatment   as an adjunct therapy to botulinum toxin in the treatment of cervical dystonia. Background: Botulinum toxin…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley